Stuart Kloda, MD – Alcohol Addiction – Naltrexone – Topamax – Baclofen – Neurontin – New York City
Stuart Kloda, MD – Alcohol Addiction – Naltrexone – Topamax – Baclofen – Neurontin – New York City – www.stuartklodamd.com Call Dr. Kloda directly at (646) 713-6578 Concierge addiction treatment for New York City and New Jersey. Dr. Kloda completed a rigorous two-year Addiction Medicine fellowship at the Addiction Institute of New York, a Columbia University affiliate in Manhattan located at St. Luke’s & Roosevelt hospitals. His experience includes serving as the medical director for the inpatient drug and alcohol detoxification and rehabilitation unit at Roosevelt Hospital. Dr. Kloda cared for many patients with co-occurring psychiatric and medical illnesses. Dr. Kloda now provides discreet, confidential, one-on-one treatment in his private office at Columbus Circle. His hours are flexible, including early morning, evening, and weekend hours. In addition, Dr. Kloda is always available to his patients on his cell phone. His treatment philosophy is one of flexibility and choice. Dr. Kloda’s approach is that there are different ways to attain recovery and to maintain sobriety. He focuses on doing “what works”, and on customizing treatment to each individual patient’s unique needs and circumstances. vivitrol nyc vivitrol new york city naltrexone nyc naltrexone new york city topamax alcohol nyc baclofen alcohol new york city neurontin alcohol nyc alcoholic new york city alcoholic nyc alcoholics anonymous new york city AA meetings nyc 12-step meetings new york city suboxone doctor new york city suboxone doctors taking patients nyc addiction medicine nyc addiction counseling …
FDA approves Iclusig to treat two rare types of leukemia
Filed under: drug treatment programs in maryland
The FDA reviewed the Iclusig drug application under the agency's priority review program, which provides for an expedited six-month review for drugs that may provide safe and effective therapy when no satisfactory alternative therapy exists, or offer …
Read more on FDA.gov
Drug to Treat Opioid Addiction Places Children at Risk for Accidental Exposure
Filed under: drug treatment programs in maryland
Robert Rolfs, M.D., deputy director of UDOH, says educating buprenorphine users about the potential risk to children can prevent serious injuries. "Buprenorphine has benefits for treating addiction to heroin and prescription opioids, but it also has …
Read more on Science Daily (press release)